First estimates: HealthEquity is going to review the quarterly quarter for | 19.08.24

HealthEquity has been aware of the quarters since 03.09.2024 on 31.07.2024.

The forecasts of 14 analysts for annual EPS sales are for a value of USD 0.699 as a share and USD 0.120 as a share in the Forequarter.

HealthEquity’s $285.1 million quarter to market has a total of 13 analysts over time. Demnach das Unternehmen de Umsatz im Vergleich zum Vorjahresviertel, in dem 243.6 Millionen USD erwirtschaftet ware, um 17.07 Prozent gesteigert.

For the financial results, there are 14 analysts who have gained a share of 3.00 USD in a value of 0.650 USD in the previous period. The Umsatz taxeren 13 analysts have calculated a value of 1.17 billion USD, 999.6 million USD a year ago.

Editorial team financi.at